ADIPOQ and Miyoshi myopathy: (7) demonstrated that adiponectin may inhibit the differentiation and maturation of osteoclasts in MM patients by upregulating the expression of AdipoR1 while downregulating the phosphorylation levels of mTOR and 4EBP1.